以第一作者及通讯作者发表文章数篇；参编专著一本。

以第一和通讯作者在中华类等核心期刊和SCI收录期刊发表论文近30篇。

发表论文40余篇，参与编写专著3部，并多次受邀到省、市电视台、广播电台做肛肠及大肠癌方面的健康讲座。

以第一作者/通讯作者在Mol cancer、BBA - Molecular Basis of Disease、Frontiers in cell and developmental biology、cell death discovery等杂志发表SCI论文6篇，累计IF > 30，发表中文核心期刊6篇

作为第一或通讯作者发表 SCI 论文 40 余篇，代表文章如下：

 (1) Wang G（#）, Yu J（#）, Yang Y, Liu X, Zhao X, Guo X, Duan T（*）, Lu C（*）, Kang J（*）.Whole-transcriptome sequencing uncovers core regulatory modules and gene signatures of human fetal growth restriction. Clin Transl Med. 2020 Jan 28;9(1):9. 

(2) Zou G（#）, Liu T（#）, Guo L, Huang Y, Feng Y, Duan T（*）. MicroRNA-32 silences WWP2 expression to maintain the pluripotency of human amniotic epithelial stem cells and β islet-like cell differentiation. Int J Mol Med. 2018;41(4):1983-1991. 

(3) Sun L（#）, Zou G, Yang Y, Zhou F, Duan T（*）. Risk factors for fetal death after radiofrequency ablation for complicated monochorionic twin pregnancies. Prenat Diagn. 2018;38(7):499-503.

 (4) Li H（#）, Yao J, Chang X, Wu J, Duan T（*）, Wang K（*）. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia. Reproduction. 2018;155(3):297-306. 

(5) Chang X（#）, Yao J（#）, He Q, Liu M, Duan T（*）, Wang K（*）. Exosomes From Women With Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells. Hypertension. 2018;72(6):1381-1390. 

(6) Chang X（#）, Li H（#）, Li Y, He Q, Yao J, Duan T（*）, Wang K（*）. RhoA/MLC signaling pathway is involved in Δ⁹-tetrahydrocannabinol-impaired placental angiogenesis. Toxicol Lett. 2018 Mar 15;285:148-155. 

(7) Jia Y（#）, Li T（#）, Huang X, Xu X, Zhou X, Jia L, Zhu J, Xie D, Wang K, Zhou Q, Jin L, Zhang J, Duan T（*）. Dysregulated DNA Methyltransferase 3A Upregulates IGFBP5 to Suppress Trophoblast Cell Migration and Invasion in Preeclampsia. Hypertension. 2017 Feb;69(2):356-366. 

(8) Chang X（#）, Bian Y（#）, He Q, Yao J, Zhu J, Wu J, Wang K（*）, Duan T（*）. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction. Cell Physiol Biochem. 2017;42(2):537-550. 

(9) Huang Y（#）, Wu Y, Chang X, Li Y, Wang K（*）, Duan T（*）. Effects of Human Umbilical Cord Mesenchymal Stem Cells on Human Trophoblast Cell Functions In Vitro. Stem Cells Int. 2016;2016:9156731. 

(10) Meng M（#）, Li X（#）, Ge H（#）, Chen F, Han M, Zhang Y, Kang D, Xie W, Gao Z, Pan X, Dai P, Chi F, Chen S, Liu P, Zhang C, Cao J, Jiang H, Xu X, Wang W（*）, Duan T（*）. Noninvasive prenatal testing for autosomal recessive conditions by maternal plasma sequencing in a case of congenital deafness. Genet Med. 2014 Dec;16(12):972-6.

第一作者及通讯作者发表SCI论文40余篇（单篇最高影响因子:27.398）。                                                                                                                                                                                         1. Chen L, Zhou LL, Wang CH, Han Y, Lu YL, Liu J, Hu XC, Yao TM, Lin Y, Liang SJ, Shi S*, Dong CY*. Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers. Adv. Mater. 2019, 31, 1904997, doi:10.1002/adma. 201904997. (IF:27.398) (通讯作者) 2. Mengyao Chen†, Jingxian Yang†, Lulu Zhou, Xiaochun Hu, Chunhui Wang, Keke Chai, Ruihao Li, Lei Feng, Yanting Sun, Chunyan Dong* and Shuo Shi *, A Dual-Responsive and ROS-augmented Nanoplatform for Chemo /Photodynamic /Chemodynamic Combination Therapy of Triple Negative Breast Cancer, Acs Applied Materials & Interfaces, 2021, Dec 22. (IF: 9.229) (通讯作者) 3. Lei Feng†, Mengyao Chen†, Ruihao Li, Lulu Zhou, Chunhui Wang, Pingting Ye, Xiaochun Hu, Jingxian Yang, Yanting Sun, Zhounan Zhu, Keke Chai, Kang Fang, Shuo Shi* and Chunyan Dong*, Biodegradable Oxygen-producing Manganese-chelated Metal Organic Frameworks for Tumor-targeted Synergistic Chemo/photothermal/photodynamic Therapy, Acta Biomaterialia, 2021,  (IF: 8.943) (通讯作者) 4. Lulu Zhou†, Jinjin Chen†, Ruihao Li, Lizhen Wei, Haitao Xiong, Chunhui Wang, Keke Chai, Mengyao Chen, Zhounan Zhu, Tianming Yao, Yun Lin, Chunyan Dong* and Shuo Shi*, Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferropotosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent in Situ Bleomycin Toxification, Small, 2021, 2103919.  (IF: 13.281) (通讯作者) 5. Lulu Zhou†, Jinjin Chen†, Yunhao Sun, Keke Chai, Zhounan Zhu, Chunhui Wang,  Mengyao Chen, Wenmei Han, Xiaochun Hu, Ruihao Li,  Tianming Yao, Hui Li, Chunyan Dong* and Shuo Shi*, A Self-Amplified Nanocatalytic System for Achieving "1+1+1>3" Chemodynamic Therapy on Triple Negative Breast Cancer, Journal of Nanobiotechnology, 2021, 19, 261. (IF: 10.432) (通讯作者) 6. Yanting Sun,† Yuling Li,† Shuo Shi,* and Chunyan Dong*, Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems, Molecules 2021, 26(9), 2703. (IF: 4.411) (通讯作者) 7. Mengyao Chen, Chunyan Dong* and Shuo Shi *, Nanoparticle-Mediated siRNA Delivery and Multifunctional modification strategies for Effective Cancer Therapy, Advanced Materials Technologies, 2021, 202001236.  (IF: 7.848) (通讯作者) 8. Xiaochun Hu#,Yonglin Lu# , Wenrong Zhao, Menglin Sun, Ruihao Li, Lei Feng, Tianming Yao, Chunyan Dong*, Shuo Shi*, A PDA-DTC/Cu-MnO2 Nanoplatform for MR Imaging and Multi-Therapy of Triple-Negative Breast Cancer, Chem. Comm, 2021, 57, 4158-4161.  (IF: 6.224) (通讯作者) 9. Wenrong Zhao#, Xiaochun Hu#, Wenhui Li, Ruihao Li, Jinjin Chen, Lulu Zhou, Sufeng Qiang, Wenjing Wu, Shuo Shi,* and Chunyan Dong*, M2-like TAMs Function Reversal Contributes to Breast Cancer Eradication by Combination Dual Immune Checkpoint Blockade and Photothermal Therapy. Small, 2021, 17, 202007051. (IF: 13.281) (通讯作者) 10. Pingting Ye#, Zhuolin Guo#, Yanfei Zhang, Chunyan Dong*, Ming Li*, Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis, Front Oncol 11 (2021) 676598. (IF: 6.244) (通讯作者) 11. Shujing Liang#, Jingxian Yang#, Yun Lin, Tong Li, Wenrong Zhao, Jun Zhao*, Chunyan Dong*. Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review. Frontiers in Immunology. 2021: 12:682262. (IF: 7.563) (通讯作者) 12. Yang JX, Wang CH, Shi S*, Dong CY*. Nanotechnologies for enhancing cancer immunotherapy. Nano Res. 2020, doi.org/10.1007/s12274-020-2904-8. (IF: 8.183) (通讯作者) 13. Liang SJ, Sun ML, Lu YL, Shi S, Yang YT, Lin Y, Feng C, Liu J and Dong CY*. Cytokine-induced killer cells-assisted tumor-targeting delivery of Her-2 monoclonal antibody-conjugated gold nanostars with NIR photosensitizer for enhanced therapy of cancer. Journal of Materials Chemistry B, 2020, 8, 8368 – 8382. (IF: 6.331) (通讯作者) 14. Chen JJ, Zhou LL, Wang CH, Sun YH, Lu YL, Hu XC, Chen MY, Chen L, Chai KK, Yao TM, Shi S*, Dong CY*. Multifunctional SN38-Conjugated Nanosystem for Defeating Myelosuppression and Diarrhea Induced by Irinotecan On Esophageal Cancer. Nanoscale. 2020, doi: 10.1039/D0NR06266A. (IF:6.895) (通讯作者) 15. Zhou LL, Chen L, Hu XC, Lu YL, Liu WJ, Yao TM, Dong CY*, Shi S*. A Cu9S5 nanoparticle-based CpG delivery system for synergistic photothermal-, photodynamic- and immunotherapy. Commun. Biol. 2020, doi: 10.1038/s42003-020-1070-6. (IF尚未统计) (共同通讯作者) 16. Wang CH, Yang JX, Dong CY*, Shi S*. Glucose oxidase related cancer therapy. Adv. Ther. 2020 (IF尚未统计)(共同通讯作者) 17. Feng C, Wang K, Lin Y, Song ZW, Lu YL, Liu J, Zhu DL, Li YY*, Dong CY*. Extracellular retention of a cyclopamine nanoformulation leveraging larger size and more negative charge for improved breast cancer treatment. J Mater Chem B, 2018, 6(12): 1834-1843 (IF: 5.047) (通讯作者) 18. Song ZW, Lin Y, Zhang X, Feng C, Lu YL, Gao Y, Dong CY*. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects. International journal of nanomedicine. 2017;12:1941-1958. (IF:4.370) (通讯作者) 19. Song ZW, Zhang X, Lin Y, Wei YZ, Liang SJ, Dong CY*. LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2. J Cell Mol Med, 2019, 23: 7554–7565 (IF:4.658) (通讯作者) 20. Hu X, Lu Y, Shi X, Yao T, Dong CY*, Shi S*. Integrating in situ formation of nanozyme with mesoporous polydopamine for combined chemo, photothermal and hypoxiaovercoming photodynamic therapy. Chem. Commun, 2019,55, 14785-14788 (IF: 6.164) (共同通讯作者) 21. Hu X, Lu Y, Zhou L, Chen L, Yao T, Liang S, Han J, Dong CY*, Shi S*. Post Syntheses Strategy to Integrate Porphyrinic Metal-Organic Frameworks with CuS NPs for Synergistic Enhanced Photo-therapy. J. Mater. Chem. B, 2020, DOI: 10.1039/C9TB02597A. (IF: 5.047) (共同通讯作者) 22. Dong HQ, Dong CY, Ren TB, Li YY, Shi DL. Surface-engineered graphene-based nanomaterials for drug delivery. Journal of biomedical nanotechnology. 2014;10:2086-106. （IF:5.068）（并列第一作者） 23. Zhu HY, Dong CY, Dong HQ, Ren TB, Wen XJ, Su JS, Li YY. Cleavable PEGylation and hydrophobic histidylation of polylysine for siRNA delivery and tumor gene therapy. ACS applied materials & interfaces. 2014;6:10393-407. （IF:6.723）（并列第一作者） 24. Cai XJ, Dong CY, Dong HQ, Wang GM, Pauletti GM, Pan XJ, Shi DL. Effective gene delivery using stimulus-responsive catiomer designed with redox-sensitive disulfide and acid-labile imine linkers. Biomacromolecules. 2012;13:1024-34. （IF: 5.738）（并列第一作者） 25. Feng C, Chen L, Lu YL, Liu J, Liang SJ, Lin Y, Li YY*, Dong CY*. Programmable Ce6 delivery via cyclopamine based tumor microenvironment modulating nano-system for enhanced photodynamic therapy in breast cancer. Front. Chem., 2019; 7, 853 (IF: 3.782) (通讯作者) 26. Zhu DL, Zhang X, Lin Y, Liang SJ, Song ZW*, Dong CY*. MT1JP inhibits tumorigenesis and enhances cisplatin sensitivity of breast cancer cells through competitively binding to miR-24-3p. Am J Transl Res.  2019; 11(1): 245–256. (IF:3.061) (通讯作者) 27. Feng C, Zhu DL, Chen L, Lu YL, Liu J, Kim NY, Liang SJ, Zhang X, Lin Y, Ma YB*, Dong CY*. Targeted Delivery of Chlorin e6 via Redox Sensitive Diselenide-Containing Micelles for Improved Photodynamic Therapy in Cluster of Differentiation 44-Overexpressing Breast Cancer. Front Pharmacol. 2019; 10: 369. (IF: 3.845) (通讯作者) 28. Lu YL, Ma YB, Feng C, Zhu DL, Liu J, Chen L, Liang SJ*, Dong CY*. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression. Journal of Cancer. 2019; 10(10): 2357–2368. (IF: 3.249) (通讯作者) 29. Liu J, Song ZW, Feng C, Lu YL, Zhou Y, Lin Y, Dong CY*. The long non-coding RNA SUMO1P3 facilitates breast cancer progression by negatively regulating miR-320a. Am J Transl Res, 2017; 9(12): 5594–5602. (IF:3.061) (通讯作者) 30. Song ZW, Feng C, Lu YL, Gao Y, Lin Y, Dong CY*. Overexpression and biological function of MEF2D in human pancreatic cancer. Am J Transl Res. 2017; 9(11):4836-4847. (IF:3.061) (通讯作者) 31. Song Z, Zhang X, Ye XJ, Feng C, Yang G, Lu YL, Lin Y, Dong CY*. High Expression of Stromal Cell-Derived Factor 1 (SDF-1) and NF-kappaB Predicts Poor Prognosis in Cervical Cancer. Medical science monitor: international medical journal of experimental and clinical research. 2017;23:151-7. (IF:1.894) (通讯作者) 32. Song Z, Lu YL, Zhang X, Wang HP, Han JY, Dong CY*. Novel curcumin-loaded human serum albumin nanoparticles surface functionalized with folate: characterization and in vitro/vivo evaluation. Drug design, development and therapy. 2016;10:2643-9. (IF:2.935) (通讯作者) 33. Song Z, Shao C, Feng C, Lu YL, Gao Y, Dong CY*. Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis. Ther Clin Risk Manag. 2016;12:763-9. (IF:1.995) (通讯作者) 34. Song ZW, Gao Y, Ye XJ, Zhang X, Yang G, Feng C, Lu YL； Dong CY*. Increased expression of PDGF-BB predicts metastasis and poor prognosis in ovarian cancer patients. International journal of clinical and experimental pathology. 2016;9:5487-92. (IF:1.396) (通讯作者) 35. Song ZW, Lin Y, Ye XJ, Feng C, Lu YL, Yang G, Dong CY*. Expression of IL-1 alpha and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer. Med Sci Monitor. 2016;22:4475-81. (IF:1.894) (通讯作者) 36. Song ZW, Lin Y, Zhang X, Ye XJ, Yang G, Feng C, Lu YL, Dong CY*. Expression of FAP is correlated with clinical prognosis in ovarian cancer patients. International journal of clinical and experimental medicine. 2016;9:11379-84. (IF:0.833) (通讯作者) 37. Feng C, Li XY, Zhang XM, Zhang X, Gao Y, Dong CY*. RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer. Drug design, development and therapy. 2015;9:4613-20. (IF: 2.935) (通讯作者) 38. Li YY, Chen YQ, Dong HQ, Dong CY*. Supramolecular, prodrug-based micelles with enzyme-regulated release behavior for controlled drug delivery. Medchemcomm. 2015;6:1874-81. (IF:2.342) (通讯作者) 39. Dong HQ, Dong CY, Xia WJ, Li YY, Ren TB. Self-assembled, redox-sensitive, H-shaped pegylated methotrexate conjugates with high drug-carrying capability for intracellular drug delivery. Medchemcomm. 2014;5:147-52 （IF:2.342）（并列第一作者） 40. Chu M, Dong CY, Zhu HY, Cai XJ, Dong HQ, Ren TB, Li YY. Biocompatible polyethylenimine-graft-dextran catiomer for highly efficient gene delivery assisted by a nuclear targeting ligand. Polym Chem-Uk. 2013;4:2528-39. （IF:4.927）（并列第一作者） 41. Li DL, Dong CY*, Gao Y. A simple and sensitive HPLC-UV method for the determination of swainsonine in rat plasma and its application in a pharmacokinetic study. Arzneimittel-Forschung. 2012;62:209-12. (IF:0.693) (通讯作者) 42. Dong HQ, Dong CY, Feng Y, Ren TB, Zhang ZH, Li L, Li YY. Engineering of peglayted camptothecin into core-shell nanomicelles for improving solubility, stability and combination delivery. Medchemcomm. 2012;3:1555-1561.（IF: 2.342）（并列第一作者）

发表及参与发表多篇论文，如，TEST1系列血沉仪参考范围的探索；Citrullinated fibronectin inhibits the apoptosis and promotes the secretion of pro-inflammatory cytokines in fibroblast-like synoviocytes in rheumatoid arthritis. 等。

1. H. Deng ，A. A. Gerencser，H. Jasper，Signal integration by Ca(2+) regulates intestinal stem-cell activity，Nature，2015.01.01，528（7581）：212~217 2. H. Deng ，M. W. Dodson，H. Huang，M. Guo，The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila，Proc Natl Acad Sci U S A，2008.01.01，105（38）：14503~14508 3. H. Deng ，H. Jasper，Sexual Dimorphism: How Female Cells Win the Race，Curr Biol，2016.01.01，26（5）：R212~215 4. H. Deng ，D. Xia，B. Fang，H. Zhang，The Flightless I homolog, fli-1, regulates anterior/posterior polarity, asymmetric cell division and ovulation during Caenorhabditis elegans development，Genetics，2007.01.01，177（2）：847~860 5. H. Deng ，Y. Sun，Y. Zhang，X. Luo，W. Hou，L. Yan，Y. Chen，E. Tian，J. Han，H. Zhang，Transcription factor NFY globally represses the expression of the C. elegans Hox gene Abdominal-B homolog egl-5，Dev Biol，2007.01.01，308（2）：583~592 6. N. M. Luis ，L. Wang，M. Ortega，H. Deng，S. D. Katewa，P. W. Li，J.Karpac，H. Jasper，P. Kapahi，Intestinal IRE1 Is Required for Increased Triglyceride Metabolism and Longer Lifespan under Dietary Restriction，Cell Rep，2016.01.01，17（5）：1207~1216

以第一和共一作者发表SCI论文11篇